Valuation: Elite Health Systems Inc.

Capitalization 23.55M 20.35M 19.16M 17.33M 32.07M 2.02B 36.12M 223M 86.9M 927M 88.35M 86.49M 3.38B P/E ratio 2023
-5.12x
P/E ratio 2024 -5.99x
Enterprise value 19.59M 16.92M 15.93M 14.42M 26.67M 1.68B 30.04M 185M 72.28M 771M 73.49M 71.94M 2.82B EV / Sales 2023
-
EV / Sales 2024 -
Free-Float
78.36%
Yield 2023 *
-
Yield 2024 -
More valuation ratios * Estimated data
Dynamic Chart
1 day+24.29%
1 week-0.90%
Current month+10.97%
1 month+59.42%
3 months+41.24%
6 months+35.80%
Current year+37.50%
More quotes
1 week 0.88
Extreme 0.885
1.5
1 month 0.76
Extreme 0.7612
1.5
Current year 0.69
Extreme 0.69
1.5
1 year 0.52
Extreme 0.515
1.94
3 years 0.04
Extreme 0.0432
1.94
5 years 0.04
Extreme 0.0432
1.94
10 years 0.04
Extreme 0.0432
1.94
More quotes
Manager TitleAgeSince
Chief Executive Officer 77 10/07/2024
Corporate Officer/Principal - -
Sales & Marketing 79 01/05/1999
Director TitleAgeSince
Chairman 80 01/01/1996
Director/Board Member 73 01/05/1999
Director/Board Member 55 17/04/2023
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+24.29%-0.90%+98.27%+479.25% 18.95M
+1.11%-2.58%+9.05%+88.93% 88.43B
+0.96%+5.18%+10.60%-28.79% 83.14B
+0.61%+0.87%+50.32%+47.32% 28.44B
-2.71%-2.63%-16.75%+24.58% 24.11B
+0.65%+3.77%+33.25%+16.51% 21.76B
+1.16%+3.10%+28.96%+36.41% 19.76B
+0.65%+0.10%+27.48%-2.25% 16.7B
+2.56%-3.67%+17.61%+162.35% 14.99B
-0.20%-2.73%+31.63%+6.17% 14.09B
Average +2.91%-0.14%+29.04%+83.05% 31.14B
Weighted average by Cap. +0.69%+0.35%+16.62%+35.26%
See all sector performances

Financials

2023 2024
Net sales - -
Net income -816K -705K -664K -601K -1.11M -69.88M -1.25M -7.71M -3.01M -32.11M -3.06M -3M -117M -2.06M -1.78M -1.67M -1.51M -2.8M -176M -3.15M -19.42M -7.58M -80.85M -7.71M -7.55M -295M
Net Debt -381K -329K -310K -280K -519K -32.63M -584K -3.6M -1.41M -14.99M -1.43M -1.4M -54.76M -3.96M -3.42M -3.22M -2.92M -5.4M -339M -6.08M -37.44M -14.62M -156M -14.86M -14.55M -569M
More financial data * Estimated data
Logo Elite Health Systems Inc.
Elite Health Systems Inc., formerly U.S. NeuroSurgical Holdings, Inc., through its wholly owned subsidiaries, holds interests in radiological treatment facilities. It owns and operates stereotactic radiosurgery centers, utilizing gamma knife technology. It owns, or holds interests in, the gamma knife and radiation treatment centers, and charges the hospital or medical facility where the unit is housed and maintained, based on utilization. It is also focused on developing cancer centers featuring radiation therapy. These centers utilize linear accelerators with Intensity Modulated Radiation Therapy and Image Guided Radiation Therapy capabilities. It is focused on launching and development of Medicare advantage plans for seniors by its subsidiaries, Elite Health Plan and Elite Health Plan of Nevada, Inc.
Employees
3
More about the company
Date Price Change Volume
12/06/25 1.100 $ +24.29% 4,150
11/06/25 0.8850 $ -19.55% 800
10/06/25 1.100 $ -8.33% 1,302
09/06/25 1.200 $ +6.19% 51,900
06/06/25 1.130 $ +1.80% 4,609

Delayed Quote OTC Markets, June 12, 2025 at 07:10 pm

More quotes